Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-12-02 ZELDIS JEROME B Director Option exercise 10b5-1 +12,000 $30.86 $370K 26,500
2024-12-02 ZELDIS JEROME B Director Sale 10b5-1 −5,699 $50.52 $288K 20,801
2024-12-02 ZELDIS JEROME B Director Sale 10b5-1 −2,634 $51.43 $135K 18,167
2024-12-02 ZELDIS JEROME B Director Sale 10b5-1 −3,667 $52.39 $192K 14,500
2024-12-02 ZELDIS JEROME B Director Option exercise · Stock Option (Right to Buy) 10b5-1 −12,000 0
2024-12-02 ZELDIS JEROME B Director Option exercise · Stock Option (Right to Buy) 10b5-1 −12,000 0
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +3,105 $51.00 $158K 55,533
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −2,497 $51.34 $128K 53,036
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −608 $52.24 $32K 52,428
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +14,695 $51.00 $749K 67,123
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −9,919 $51.53 $511K 57,204
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −4,776 $52.45 $251K 52,428
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −3,105 14,695
2024-12-02 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −14,695 0
2024-12-02 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +1,960 $51.00 $100K 94,349
2024-12-02 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −1,960 $52.17 $102K 92,389
2024-12-02 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +83,640 $51.00 $4.3M 176,029
2024-12-02 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −83,640 $52.26 $4.4M 92,389
2024-12-02 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −1,960 83,640
2024-12-02 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −83,640 0

Page 32 of 41 · 804 trades